News
Zacks Investment Research on MSN5h
KRYS Begins Dosing With Gene Therapy in Rare Eye Disease, Stock UpShares of Krystal Biotech KRYS gained 3.9% yesterday after the company announced that it had dosed the first patient in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback